Sarepta Therapeutics(DE:AB3A)
€14.84-0.02 (-0.13%)
DE:AB3A
Sarepta Therapeutics earnings date
€14.84
At close:-0.02 (-0.13%)
Sarepta Therapeutics (AB3A) Q4 2023 Earnings Report
6 Followers
DE:AB3A Q4 2023 EPS Results
- Actual EPS
- EUR 0.42
- Consensus EPS
- EUR 0.06
- Beat/Miss
- Beat by +EUR 0.36
- One Year Ago EPS
- -EUR 1.12
DE:AB3A Q4 2023 Revenue Results
- Actual Revenue
- EUR 358.66M
- Expected Revenue
- EUR 349.98M
- Beat/Miss
- Beat by +EUR 8.68M
- YoY Revenue Growth
- +53.54%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 02/28/2024
- Time
- After Close
- Conference Call
- Wednesday, February 28, 2024
DE:AB3A Upcoming Earnings
Sarepta Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
DE:AB3A Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AB3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.33- | -3.55 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.07-0.24 | -1.63 | 85.00% (+1.38) | |
| Aug 05, 2026 | 2026 (Q2) | 0.20-0.05 | 1.71 | -102.65% (-1.75) | |
| May 06, 2026 | 2026 (Q1) | 0.882.60 | -4.16 | 162.61% (+6.76) | |
| Feb 25, 2026 | 2025 (Q4) | -1.08-3.55 | 1.36 | -362.00% (-4.91) | |
| Nov 03, 2025 | 2025 (Q3) | -0.66-1.63 | 0.31 | -629.41% (-1.93) | |
| Aug 06, 2025 | 2025 (Q2) | 0.751.71 | 0.06 | 2600.00% (+1.65) | |
| May 06, 2025 | 2025 (Q1) | -2.90-4.16 | 0.33 | -1343.24% (-4.49) | |
| Feb 26, 2025 | 2024 (Q4) | 1.701.36 | 0.42 | 219.15% (+0.93) | |
| Nov 06, 2024 | 2024 (Q3) | -0.070.31 | -0.42 | 173.91% (+0.72) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
